11 results · 26ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CERAMIC SPHERICAL CMC IMPLANT (SUBJECT TO MARKETING APPROVAL)

FDA 510(k)
FDA Class 2 ·Orthopedic

CALCIPULPE

FDA 510(k)
FDA Class 2 ·Dental

ASAHI CHIKAI Neurovascular Guide Wire (Round Curve)

FDA 510(k)
FDA Class 2 ·Cardiovascular

HEARTSTART ONSITE

FDA Adverse Event
Malfunction ·PHILIPS MEDICAL SYSTEMS·Product code MKJ·June 9, 2014

9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·January 25, 2013

PRECISION XTRA

FDA Adverse Event
Malfunction ·Product code NBW·January 13, 2011

NASAL-AIRE

FDA Adverse Event
Malfunction ·INNOMED TECHNOLOGIES·Product code BYE·January 6, 2003

MONOCRYL UD 27IN USP2-0

FDA Adverse Event
Malfunction ·ETHICON INC.·Product code GAN·October 25, 2024

MONOCRYL UD 27IN USP2-0

FDA Adverse Event
Malfunction ·ETHICON INC.·Product code GAN·October 25, 2024

CPT Hip System, Parts 00-8114-002-10 and 00-8011-004-00 Hip joint metal/polymer semi-constrained cemented prosthesis. The CPT Hip System is indicated for cemented use in: Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head, and nonunion of previous fractures of the femur. Patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral epiphysis. Patients suffering from disability due to previous fusion. Patients with previously failed endoprostheses and/or total hip components in the affected extremity. Patients with acute femoral neck fractures. 510(k) K960658

FDA Enforcement
Class II ·Terminated·Zimmer, Inc.·January 8, 2014

CPT Hip System, Parts 00-8114-002-10 and 00-8011-004-00 Hip joint metal/polymer semi-constrained cemented prosthesis. The CPT Hip System is indicated for cemented use in: Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head, and nonunion of previous fractures of the femur. Patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral epiphysis. Patients suffering from disability due to previous fusion. Patients with previously failed endoprostheses and/or total hip components in the affected extremity. Patients with acute femoral neck fractures. 510(k) K960658

FDA Recall
Terminated ·Zimmer, Inc.·Product code JDI·December 10, 2013